IMMUNOREACTIVE LUTEINIZING HORMONE AND PROGESTERONE DURING PREGNANCY AND FOLLOWING GONADOTROPHIN ADMINISTRATION IN BEAGLE BITCHES

1973 ◽  
Vol 72 (3) ◽  
pp. 573-581 ◽  
Author(s):  
Gwyneth E. Jones ◽  
A. R. Boyns ◽  
E. T. Bell ◽  
D. W. Christie ◽  
M. F. Parkes

ABSTRACT Immunoreactive canine luteinizing hormone (IRCLH) and progesterone were measured in the plasma of Beagle bitches. Changes in plasma hormone concentrations during pregnancy were similar to those seen in the non-pregnant animal during metoestrus. Administration of pregnant mares' serum gonadotrophin (PMSG) and human chorionic gonadotrophin (HCG) to anoestrous bitches induced oestrus. However, the duration of progesterone secretion was shorter than that seen in pregnant bitches. Treatment appeared to stimulate the secretion of IRCLH and in some animals plasma levels reached a maximum some weeks after the end of oestrus.

1974 ◽  
Vol 61 (1) ◽  
pp. 45-51 ◽  
Author(s):  
G. S. GREENWALD

SUMMARY When hamsters were hysterectomized on day 1 of pregnancy, ovulation occurred 17 days later. On day 12 of this prolonged pseudopregnancy, plasma levels of progesterone were approximately half of those of intact animals on the same day of pregnancy. The concentration of follicle-stimulating hormone in the pituitary of the hysterectomized animals was only half that of the pregnant group, but luteinizing hormone concentrations were similar. The massive proliferation of antral follicles characteristic of pregnant hamsters on day 12 was not found in the hysterectomized animals; injection of 20 i.u. human chorionic gonadotrophin (HCG) on day 12 resulted in the ovulation of 31 and 6 ova respectively, but priming the hysterectomized hamsters with pregnant mare serum gonadotrophin (before HCG) resulted in superovulation. After hysterectomy on day 9 of pregnancy, by day 12 there was a rapid decline in luteal activity as shown histologically by the onset of structural luteolysis and a concomitant fall in luteal weight, and luteal and plasma levels of progesterone. These effects were partially or completely reversed by daily injection of 1 mg prolactin on days 9–11. The results indicate that hysterectomy before the establishment of the placenta results in the sustained release by the pituitary of prolactin and gonadotrophins, but most likely at lower levels than in pregnant animals. However, hysterectomy on day 9 abruptly removes the placental source of a prolactin-like hormone and the pituitary cannot respond in time to prevent luteolysis.


1973 ◽  
Vol 57 (2) ◽  
pp. 299-305 ◽  
Author(s):  
D. T. BAIRD ◽  
R. A. COLLETT

SUMMARY The response of the ovine corpus luteum to repeated infusions of luteinizing hormone (LH) or of human chorionic gonadotrophin (HCG) was tested in four ewes with the left ovary autotransplanted to the neck. Constant infusion for 1 h of either LH (100 or 1000 μg/h) or HCG (200 i.u./h) via the ovarian artery stimulated a temporary increase in secretion of progesterone which fell to control levels by 60 min. Ovarian blood flow increased progressively (P < 0·05) throughout the infusion of gonadotrophin in three of the five experiments. A second infusion of either gonadotrophin after a further control hour failed to stimulate progesterone secretion. These results suggest that ovine luteal tissue rapidly becomes refractory to the steroidogenic effect of LH in vivo.


1963 ◽  
Vol 43 (1) ◽  
pp. 155-160
Author(s):  
Jørgen Falck Larsen ◽  
Christian Hamburger

ABSTRACT Various modifications of the Parlow test for luteinizing hormone (ovarian ascorbic acid depletion in rats) were tried. Human chorionic gonadotrophin was used instead of hypophyseal luteinizing hormone. The precision of the method was found to be so low, however, that the test could not be used for routine clinical analysis. The low precision found in this and other laboratories is thought to be due to the strains of rats used.


1971 ◽  
Vol 67 (2) ◽  
pp. 262-276 ◽  
Author(s):  
P. Petrusz ◽  
C. Robyn ◽  
E. Diczfalusy

ABSTRACT Forty-two antisera were prepared in rabbits against human chorionic gonadotrophin (HCG), human hypophysial gonadotrophin (HHG), human urinary luteinizing hormone (LH) and human menopausal gonadotrophin (HMG) preparations. The gonadotrophic profiles of the antigens were previously characterized by bioassay, immunoassay and bioimmunoassay methods. The 25 most potent antisera were tested in statistically valid bioassays for their HCG and follicle stimulating hormone (FSH) neutralizing activities as well as for their neutralizing potencies against the FSH-like activity present in HCG preparations. The anti-HCG/anti-FSH ratios of the anti-HCG sera tested varied between 6.2 and > 254, while those of the anti-HHG, anti-LH and anti-HMG sera were close to 2. It was found that the total dose of immunological activity (anti-HCG neutralizing and anti-FSH neutralizing potency) rather than that of the biological activity administered to the rabbits was decisive for obtaining antisera with high anti-HCG and anti-FSH titers. Immunization with a highly purified HCG preparation (> 17 000 IU/mg) resulted in antisera exhibiting lower anti-HCG/anti-FSH ratios than did immunization with partially purified preparations. A highly purified urinary LH preparation which did not contain any detectable FSH activity gave rise to antisera exhibiting anti-HCG/anti-FSH ratios of approximately 2.0. These highly purified HCG and LH preparations were shown previously to possess high anti-FSH neutralizing potencies (Petrusz et al. 1971b). Booster injections did not change significantly the quality or the titer of the antigonadotrophic sera studied. The HCG neutralizing potency of anti-HCG sera was approximately 3 times higher when assayed against a highly purified HCG preparation (> 17 000 IU/mg) as compared to potency estimates obtained against the laboratory standard of HCG (about 2000 IU/mg). It is suggested that consideration should be given to the establishment of standard preparations of antigonadotrophic sera. It is concluded that bioimmunoassays are more suitably than conventional bioassay methods for the assessment of the antigenic purity of human gonadotrophin preparations.


1978 ◽  
Vol 76 (3) ◽  
pp. 487-491 ◽  
Author(s):  
K. YAMASHITA ◽  
M. MIENO ◽  
T. SHIMIZU ◽  
ER. YAMASHITA

The rate of secretion of 17-oxosteroids by the testes of anaesthetized dogs in vivo was used as an index of LH secretion. Intracarotid injection of luteinizing hormone releasing hormone (LH-RH, 1, 5 or 10 μg/kg body wt) resulted in an increase in the testicular 17-oxosteroid secretion which was roughly proportional to the dose administered and which reached a maximum 60 min after the injection. Testicular output of 17-oxosteroids was unaffected by administration of melatonin (10 or 100 μg/kg body wt) into the carotid artery. When LH-RH (5 μg/kg) was injected into the carotid artery 3 h after intracarotid injection of melatonin (10 or 100 μg/kg), the testicular response to LH-RH was considerably diminished. Pretreatment with melatonin (100 μg/kg) did not alter the testicular response to human chorionic gonadotrophin (20 i.u./kg body wt) given i.v. It is concluded that melatonin may act directly on the anterior pituitary gland in dogs to inhibit the LH-RH-induced release of LH.


1995 ◽  
Vol 146 (1) ◽  
pp. 169-176 ◽  
Author(s):  
H Kishi ◽  
K Taya ◽  
G Watanabe ◽  
S Sasamoto

Abstract Plasma and ovarian levels of inhibin were determined by a radioimmunoassay (RIA) at 3-h intervals throughout the 4-day oestrous cycle of hamsters. Plasma concentrations of FSH, LH, progesterone, testosterone and oestradiol-17β were also determined by RIAs. In addition, hamsters were injected at various times with human chorionic gonadotrophin (hCG) to determine the follicular development. The changes in plasma concentrations of FSH after injection of antisera to oestradiol-17β (oestradiol-AS) and inhibin (inhibin-AS) on the morning of day 2 (day 1=day of ovulation) were also determined. Plasma concentrations of inhibin showed a marked increase on the afternoon of day 1, remained at plateau levels until the morning of day 4, then increased abruptly on the afternoon of day 4 when preovulatory LH and FSH surges were initiated. A marked decrease in plasma concentrations of inhibin occurred during the process of ovulation after the preovulatory gonadotrophin surges. An inverse relationship between plasma levels of FSH and inhibin was observed when the secondary surge of FSH was in progress during the periovulatory period. Plasma concentrations of oestradiol-17β showed three increase phases and these changes differed from those of inhibin. Changes in plasma concentrations of oestradiol-17β correlated well with the maturation and regression of large antral follicles. Follicles capable of ovulating following hCG administration were first noted at 2300 h on day 1. The number of follicles capable of ovulating reached a maximum on the morning of day 3 (24·8± 0·6), and decreased by 0500 h on day 4 (15·0 ± 1·1), corresponding to the number of normal spontaneous ovulations. Plasma concentrations of FSH were dramatically increased within 6 h after inhibin-AS, though no increase in FSH levels was observed after oestradiol-AS. These findings suggest that changes in the plasma levels of inhibin during the oestrous cycle provide a precise indicator of follicular recruitment, and that the changes in plasma concentrations of oestradiol-17β are associated with follicular maturation. These findings also suggest that inhibin may play a major role in the inhibition of FSH secretion during the oestrous cycle of the hamster. Journal of Endocrinology (1995) 146, 169–176


1976 ◽  
Vol 86 (1) ◽  
pp. 127-129 ◽  
Author(s):  
P. T. McGovern ◽  
J. A. Laing

Although the administration of pregnant mares' serum gonadotrophin (PMSG) to induce superovulation is a well established procedure (see Anderson, Schultz & Melampny, 1963), the unpredictability of the response to this treatment continues to impose a constraint on the commercial application of egg transfer techniques in the large domestic animals. In sheep, the additional use of human chorionic gonadotrophin (HCG) has been mainly centred on attempts to control the time of ovulation (Ortavant, Thibault & Wintenberger, 1949; Braden, Lamond & Radford, 1960; Dziuk et al. 1964; McGovern, Williams & Hancock, 1969). However, Killeen & Moore (1970) found that the proportion of follicles which rupture was increased in PMSG-treated ewes which had been given HCG at the beginning of oestrus. The purpose of the observations recorded here was to examine the possibility that a further gain in ovulation rate in PMSG-treated sheep might be obtained with the use of luteinizing hormone releasing factor (LHRF). No attempt was made to reproduce physiological levels of the releasing factor and dosage was aimed at achieving a superovulatory effect.


Sign in / Sign up

Export Citation Format

Share Document